Shenzhen Baoyuan Medical Devices Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 40,000,000 on June 9, 2022. The transaction will involve participation from existing investor, Zhejiang Tailin BioEngineering Co.,Ltd. Post the closing, the registered capital of the company will increase from CNY 10,000,000 to CNY 50,000,000. Post-closing, the investor will retain its 100% stake in the company.
Zhejiang Tailin BioEngineering Co.,Ltd
Equities
300813
CNE100003S89
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.99 CNY | -8.15% | -1.70% | -10.32% |
1st Jan change | Capi. | |
---|---|---|
-10.32% | 360M | |
+12.85% | 227B | |
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B |
- Stock Market
- Equities
- 300813 Stock
- News Zhejiang Tailin BioEngineering Co.,Ltd
- Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd